|
HYLS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.922000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.123000E-01 |
| Normal-vs-Stage2 |
7.150000E-01 |
| Normal-vs-Stage3 |
4.144200E-01 |
| Normal-vs-Stage4 |
3.126200E-01 |
| Stage1-vs-Stage2 |
5.096000E-01 |
| Stage1-vs-Stage3 |
1.855570E-01 |
| Stage1-vs-Stage4 |
4.006200E-01 |
| Stage2-vs-Stage3 |
7.996600E-01 |
| Stage2-vs-Stage4 |
2.761600E-01 |
| Stage3-vs-Stage4 |
1.142360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.875600E-01 |
| Normal-vs-AfricanAmerican |
3.548600E-01 |
| Normal-vs-Asian |
4.449400E-01 |
| Caucasian-vs-AfricanAmerican |
2.640800E-01 |
| Caucasian-vs-Asian |
5.209800E-01 |
| AfricanAmerican-vs-Asian |
8.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.360800E-01 |
| Normal-vs-Female |
5.089400E-01 |
| Male-vs-Female |
2.564600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.640600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.618000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.591800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.539600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.565400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.047200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.437600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.799400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.718000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.780800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.915200E-01 |
| Normal-vs-Grade 2 |
7.553400E-01 |
| Normal-vs-Grade 3 |
9.613800E-01 |
| Normal-vs-Grade 4 |
9.115400E-01 |
| Grade 1-vs-Grade 2 |
7.215400E-01 |
| Grade 1-vs-Grade 3 |
6.628400E-01 |
| Grade 1-vs-Grade 4 |
6.962600E-01 |
| Grade 2-vs-Grade 3 |
6.620800E-01 |
| Grade 2-vs-Grade 4 |
7.290000E-01 |
| Grade 3-vs-Grade 4 |
9.297000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.345900E-02 |
| Normal-vs-ccB subtype |
1.771000E-01 |
| ccA subtype-vs-ccB subtype |
5.011700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.747800E-01 |
| Normal-vs-N1 |
5.155600E-01 |
| N0-vs-N1 |
5.392400E-01 |
|
|
